Quick Comparison
| Tranexamic Acid | Vitamin C (L-Ascorbic Acid) | |
|---|---|---|
| Typical Concentration | Topical: 2-5% in serum or cream, applied twice daily. Oral (off-label for melasma): 250 mg twice daily — requires medical supervision. Can be combined with other brightening agents. Results visible at 8-12 weeks. Especially effective for melasma. | L-Ascorbic Acid: 10-20% at pH 2.5-3.5. Start with 10% if new to vitamin C. Apply in the morning under sunscreen for photoprotective synergy. The SkinCeuticals CE Ferulic formula (15% L-AA + 1% vitamin E + 0.5% ferulic acid) is the most studied and copied formulation. |
| Application | Topical (serum, cream) or oral (tablets, off-label). Topical preferred for safety. Oral is more effective but carries systemic risks. | Topical (serum, usually water-based). Apply to clean, dry skin in the morning before sunscreen. Store in cool, dark place. Discard when it turns dark yellow or brown. |
| Research Papers | 10 papers | 10 papers |
| Categories |
Mechanism of Action
Tranexamic Acid
Tranexamic acid (TXA) is a lysine analogue that competitively inhibits plasminogen activation—binding lysine-binding sites and preventing conversion to plasmin by tPA and uPA. Plasmin normally activates multiple pathways: converts latent TGF-beta to active form, stimulates keratinocyte release of arachidonic acid and prostaglandins (PGE2, PGF2-alpha), and increases SCF and bFGF—all stimulating melanocyte proliferation and melanogenesis. By blocking plasmin, TXA interrupts this paracrine cascade, reducing melanin through a mechanism independent of tyrosinase. TXA also inhibits VEGF and reduces angiogenesis—addressing melasma's vascular component. May reduce UV-induced plasmin in keratinocytes. This unique mechanism makes TXA synergistic with tyrosinase inhibitors for stubborn melasma.
Vitamin C (L-Ascorbic Acid)
L-Ascorbic acid donates electrons to scavenge reactive oxygen species (superoxide, hydroxyl radical, singlet oxygen) and reactive nitrogen species from UV, pollution, and metabolism—preventing oxidative damage to lipids, proteins, and DNA. It inhibits tyrosinase (copper enzyme catalyzing tyrosine to L-DOPA to dopaquinone) through copper chelation and competitive inhibition. Ascorbate is an essential cofactor for prolyl and lysyl hydroxylase—enzymes that hydroxylate collagen residues for triple-helix formation and lysyl oxidase crosslinking. Vitamin C regenerates oxidized vitamin E, creating a sustained redox cycle. Ferulic acid stabilizes both vitamins; the CE Ferulic combination provides 4-8x greater photoprotection than vitamin C alone. Penetration requires pH 2.5-3.5.
Risks & Safety
Tranexamic Acid
Rare
Topical form has minimal systemic absorption and low risk.
Vitamin C (L-Ascorbic Acid)
Common
Tingling/stinging on application (due to low pH), oxidation of product (turns yellow/brown — discard when this happens).
Serious
None.
Rare
Contact dermatitis, especially with oxidized product. May cause temporary orange staining of skin at high concentrations.
Full Profiles
Tranexamic Acid →
Originally an oral medication for heavy menstrual bleeding, tranexamic acid (TXA) has emerged as one of the most effective treatments for melasma and stubborn hyperpigmentation that does not respond to conventional treatments. It works through a unique mechanism — blocking plasmin-mediated stimulation of melanocytes — that is different from tyrosinase inhibitors, making it an excellent combination partner.
Vitamin C (L-Ascorbic Acid) →
The most potent topical antioxidant with strong clinical evidence for brightening, anti-aging, and photoprotection. L-Ascorbic Acid is the pure, active form that directly neutralizes free radicals, inhibits melanin production, and stimulates collagen synthesis. The challenge is formulation — it is notoriously unstable and must be at low pH (2.5-3.5) for skin penetration, which can cause irritation.